Transgene has received a sub-award from Emergent BioSolutions (EBS) under its existing grant of $5m from the US National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH), to advance ...
Tags: Transgene, NIH Funding
Emergent BioSolutions has received FDA approval for its supplemental Biologics License Application (sBLA) to change the administration schedule of BioThrax to a three-dose primary series of intramuscular injections at zero, one, and six ...
Tags: Medicine, Emergent BioSolutions, Anthrax Vaccine Adsorbed